Found 9 matching trials
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
EARLY_PHASE1This randomized pilot early phase I trial studies how well denosumab works ...
Location
Dana-Farber Cancer Institute
A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva
PHASE1Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Location
Biokinetica - Early Phase Institute
Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
PHASE3A randomized, double-blind, two-group parallel, placebo-controlled clinical...
Location
Shanghai sixth people's hospital
To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
PHASE3A multi-center, randomized, double-blind, comparative study to evaluate the...
Location
Beijing Cancer Hospital
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
PHASE1A randomized, double-blind and parallel group study to compare the pharmaco...
Location
The First Affiliated Hospital of Jilin University
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
PHASE3This study is a multicenter, randomized, double-blind comparative study to ...
Location
Zhejiang Provincial People's Hospital Bijie Hospital
A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis
PHASE3The primary objective of this study is to demonstrate equivalent efficacy o...
Location
Diagnostic Consultative Center Aleksandrovska
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
PHASE2This phase II trial studies how well denosumab works in treating patients w...
Location
Children's Hospital of Alabama
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
PHASE1A randomized, double-blind and parallel group study to compare the pharmaco...
Location
The First Affiliated Hospital of Jilin University